However, the acylation strategy seems to be failed in patients with severe DM, because results of the recent studies suggested that excessive glycation of human serum albumin in these patients reduces to the large extent its ability for binding to the liraglutide medicine [28]. Here, ALB is linked to diabetes mellitus.